Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease. [electronic resource]
Producer: 20160603Description: 465-76 p. digitalISSN:- 1528-0012
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Cells, Cultured
- Class I Phosphatidylinositol 3-Kinases
- Crohn Disease -- diagnosis
- Disease Models, Animal
- Humans
- Ileitis -- diagnosis
- Ileum -- enzymology
- Inositol Polyphosphate 5-Phosphatases
- Interleukin-18 -- metabolism
- Interleukin-1beta -- genetics
- Leukocytes, Mononuclear -- enzymology
- Macrophages -- enzymology
- Mice, 129 Strain
- Mice, Inbred C57BL
- Mice, Knockout
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases
- Phosphoinositide-3 Kinase Inhibitors
- Phosphoric Monoester Hydrolases -- deficiency
- Protein Kinase Inhibitors -- pharmacology
- Receptors, Interleukin-1 -- antagonists & inhibitors
- Transcription, Genetic
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.